Who
Lawrence Joseph Ellison
Executive Chairman
Company insider
Files Form 4 as: Executive Chairman, Oracle; Director, Tesla; 10% owner, Netsuite; 10% owner, Leapfrog Enterprises; Chief Executive Officer, Oracle Corp /de/.
In numbers
- Trades disclosed
- 959
- Buys
- 1
- Sells
- 276
- Bought
- $959K
- Sold
- $6.2B
- Companies
- 5
- Companies where not an officer
- 3
- First trade
- 28 Dec 2005
- Last trade
- 15 Oct 2026
- Last filed
- 19 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Oct 2026filed 19 Oct 2026 | ORCL Oracleoption or derivative · Software | SEC FORM 4 Code A | —223,099 at $0.00 | filing |
| 23 Oct 2025filed 27 Oct 2025 | ORCL Oracleoption or derivative · Software | SEC FORM 4 Code A | —571,286 at $0.00 | filing |
| 15 Jul 2025filed 17 Jul 2025 | ORCL Oracleoption or derivative · Software | SEC FORM 4 Code M | —1,500,000 at $0.00 | filing |
| 15 Jul 2025filed 17 Jul 2025 | ORCL Oracleoption or derivative · Software | SEC FORM 4 Code M | —5,000,000 at $0.00 | filing |
| 15 Jul 2025filed 17 Jul 2025 | ORCL OracleSoftware | SEC FORM 4 Code M | $76.7M1,500,000 at $51.13 | filing |
| 15 Jul 2025filed 17 Jul 2025 | ORCL OracleSoftware | SEC FORM 4 Code M | $255.7M5,000,000 at $51.13 | filing |
| 9 Jul 2025filed 11 Jul 2025 | ORCL Oracleoption or derivative · Software | SEC FORM 4 Code M | —2,500,000 at $0.00 | filing |
| 9 Jul 2025filed 11 Jul 2025 | ORCL Oracleoption or derivative · Software | SEC FORM 4 Code M | —2,500,000 at $0.00 | filing |
| 9 Jul 2025filed 11 Jul 2025 | ORCL Oracleoption or derivative · Software | SEC FORM 4 Code M | —1,000,000 at $0.00 | filing |
| 9 Jul 2025filed 11 Jul 2025 | ORCL OracleSoftware | SEC FORM 4 Code M | $127.8M2,500,000 at $51.13 | filing |
| 9 Jul 2025filed 11 Jul 2025 | ORCL OracleSoftware | SEC FORM 4 Code M | $127.8M2,500,000 at $51.13 | filing |
| 9 Jul 2025filed 11 Jul 2025 | ORCL OracleSoftware | SEC FORM 4 Code M | $51.1M1,000,000 at $51.13 | filing |
| 24 Jun 2025filed 26 Jun 2025 | ORCL Oracleoption or derivative · Software | SEC FORM 4 Code A | —5,000,000 at $0.00 | filing |
| 16 Jul 2024filed 17 Jul 2024 | ORCL Oracleoption or derivative · Software | SEC FORM 4 Code M | —1,125,000 at $0.00 | filing |
| 16 Jul 2024filed 17 Jul 2024 | ORCL OracleSoftware | SEC FORM 4 Code M | $45.5M1,125,000 at $40.47 | filing |
| 16 Jul 2024filed 17 Jul 2024 | ORCL OracleSoftware | SEC FORM 4 Sold | $147.9M1,037,873 at $142.53 | filing |
| 16 Jul 2024filed 17 Jul 2024 | ORCL OracleSoftware | SEC FORM 4 Sold | $12.5M87,127 at $143.17 | filing |
| 15 Jul 2024filed 17 Jul 2024 | ORCL Oracleoption or derivative · Software | SEC FORM 4 Code M | —1,125,000 at $0.00 | filing |
| 15 Jul 2024filed 17 Jul 2024 | ORCL OracleSoftware | SEC FORM 4 Code M | $45.5M1,125,000 at $40.47 | filing |
| 15 Jul 2024filed 17 Jul 2024 | ORCL OracleSoftware | SEC FORM 4 Sold | $82.7M579,765 at $142.64 | filing |
The newest 500 lines are listed; the numbers count every line.
News
Amazon, Google, Meta and Oracle Back Electronic Prior Authorization Push for Workers and Families in Self-Funded Health PlansORCL · medicaldaily.com · 23 Oct 2026U.S. And Israel Reportedly Plan Post-Election Iran Strike As Tesla (NASDAQ: TSLA) And SpaceX Explore MergerTSLA · foreignpolicyjournal.com · 23 Oct 2026Oracle (NYSE: ORCL) Takes On Microsoft (NASDAQ: MSFT) With Debt, Stock Sales, And Customer Prepayments In AI Infrastructure BattleORCL · foreignpolicyjournal.com · 22 Oct 2026Tesla cuts capex plan to $20 billion, raising doubts over AI ambitionsTSLA · business-standard.com · 22 Oct 2026Oracle: Bond Yields Near 9%, What The Earnings Bulls Are Missing (NYSE:ORCL)ORCL · seekingalpha.com · 22 Oct 2026Tesla (NASDAQ:TSLA) Stock Rating Reaffirmed as Outperform by Royal Bank Of CanadaTSLA · themarketsdaily.com · 22 Oct 2026
0 headlines in the last 90 days name Lawrence Joseph Ellison; 6 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.